You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Case Report
Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2025

AbstractFullPdf
Dec 2019220
Jan 2020880
Feb 202011111
Mar 2020991
Apr 2020992
May 2020373713
Jun 202016167
Jul 202019193
Aug 2020550
Sep 202018181
Oct 202018181
Nov 2020641
Dec 202010102
Jan 2021770
Feb 2021994
Mar 202114145
Apr 202111117
May 2021988
Jun 202121219
Jul 2021181811
Aug 2021994
Sep 2021999
Oct 2021202019
Nov 2021111011
Dec 202114142
Jan 2022121310
Feb 202216165
Mar 202223236
Apr 2022323310
May 202225257
Jun 202221219
Jul 202223244
Aug 202217173
Sep 202222227
Oct 202219206
Nov 202295413
Dec 2022552
Jan 2023445
Feb 202324240
Mar 2023662
Apr 2023565
May 2023557
Jun 2023992
Jul 20237710
Aug 2023664
Sep 2023552
Oct 2023551
Nov 2023991
Dec 2023473
Jan 2024677
Feb 202413132
Mar 2024552
Apr 202411115
May 2024551
Jun 2024151610
Jul 202420218
Aug 202419214
Sep 2024777
Oct 2024171711
Nov 20249102
Dec 2024664
Jan 2025171719
Feb 202595957
Mar 2025662
Apr 202526263
May 2025998
Jun 2025121313
Jul 2025110
Sep 2025110
Total933989360